COVID-19 Vaccine Caution Issued by U.K. Officials
The advice was issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program, the Associated Press reported. The regulators said they are investigating the two cases.
"As is common with new vaccines the [Medical and Healthcare Products Regulatory Agency (MHRA)] have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday," Stephen Powis, national medical director of the National Health Service, said in a statement, the AP reported. "Both are recovering well," he added.
"We know from the very extensive clinical trials that this wasn't a feature," June Raine, head of the MHRA, told a Parliamentary committee, the AP reported. "But If we need to strengthen our advice, now that we have had this experience with the vulnerable populations, the groups who have been selected as a priority, we get that advice to the field immediately."
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 11 to 15, 2021. This roundup...
FRIDAY, Jan. 15, 2021 -- The COVID-19 pandemic has had a considerable impact on life expectancy in the United States, especially among Black and Latino populations, according to a...
FRIDAY, Jan. 15, 2021 -- In April 2020, there were reductions in primary care-recorded mental illness and self-harm in the United Kingdom, according to a study published online...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.